Althea Group Holdings Ltd (ASX: AGH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Althea Group Holdings Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$8.31 million
P/E Ratio
N/A
Dividend Yield
0.00%
Shares Outstanding
406.50 million
Earnings per share
-0.058
Dividend per share
N/A
Year To Date Return
-48.72%
Earnings Yield
N/A
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Althea Group Holdings Ltd (ASX: AGH)
Latest News
Cannabis Shares
Could ASX cannabis shares be set for a resurgence?
Cannabis Shares
Which ASX cannabis share is surging 27% on record quarterly results?
Cannabis Shares
Why is the Althea share price up 20% in 4 days?
Share Gainers
Why Althea, AnteoTech, New Hope, and Omni Bridgeway shares are pushing higher
Cannabis Shares
Here's why the Althea (ASX:AGH) share price is rocketing 12% today
Cannabis Shares
These were the best performing ASX cannabis shares in October
Share Gainers
Beaten up ASX cannabis shares showing signs of life
Cannabis Shares
Althea (ASX:AGH) share price jumps 9% on cannabis drinks news
Share Market News
Why the Althea (ASX:AGH) share price is sinking 10% today
Share Gainers
Why Althea, Audinate, Perenti, & Viva Energy shares are pushing higher
Cannabis Shares
Why the Althea (ASX:AGH) share price is charging higher today
Cannabis Shares
Blazing it? How the top ASX cannabis shares performed in FY21
AGH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Althea Group Holdings Ltd
Althea Group Holdings Ltd is engaged in the manufacturing, sales, and distribution of cannabis-based medicines and recreational cannabis products. It operates in three reportable segments Pharmaceutical Cannabis, Recreational Cannabis, andCorporate in which it generates the majority of its revenue from Pharmaceutical Cannabis. It operates into four geographic segments: Australia, the United Kingdom, Canada, and others. The company earns key revenue from Australia and through the sale of medicinal cannabis products.
AGH Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 09 Sep 2024 | $0.02 | $0.00 | 0.00% | 81,808 | $0.02 | $0.02 | $0.02 |
| 06 Sep 2024 | $0.02 | $0.00 | 0.00% | 587,366 | $0.02 | $0.02 | $0.02 |
| 05 Sep 2024 | $0.02 | $0.00 | 0.00% | 1,318 | $0.02 | $0.02 | $0.02 |
| 04 Sep 2024 | $0.02 | $0.00 | 0.00% | 1,534,799 | $0.02 | $0.02 | $0.02 |
| 03 Sep 2024 | $0.02 | $0.00 | 0.00% | 667,029 | $0.02 | $0.02 | $0.02 |
| 02 Sep 2024 | $0.02 | $0.00 | 0.00% | 638,215 | $0.02 | $0.02 | $0.02 |
| 30 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,433,656 | $0.02 | $0.02 | $0.02 |
| 29 Aug 2024 | $0.02 | $0.00 | 0.00% | 10,000 | $0.02 | $0.02 | $0.02 |
| 28 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,120,119 | $0.02 | $0.02 | $0.02 |
| 27 Aug 2024 | $0.02 | $0.00 | 0.00% | 15,012 | $0.02 | $0.02 | $0.02 |
| 26 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,436,360 | $0.02 | $0.02 | $0.02 |
| 23 Aug 2024 | $0.02 | $0.00 | 0.00% | 920,036 | $0.02 | $0.02 | $0.02 |
| 22 Aug 2024 | $0.02 | $0.00 | 0.00% | 616,806 | $0.02 | $0.02 | $0.02 |
| 21 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,609,237 | $0.02 | $0.02 | $0.02 |
| 20 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,321,478 | $0.02 | $0.02 | $0.02 |
| 19 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,930,882 | $0.02 | $0.02 | $0.02 |
| 16 Aug 2024 | $0.02 | $0.00 | 0.00% | 512,037 | $0.02 | $0.02 | $0.02 |
| 15 Aug 2024 | $0.02 | $0.00 | 0.00% | 880,305 | $0.02 | $0.02 | $0.02 |
| 14 Aug 2024 | $0.02 | $0.00 | 0.00% | 1,210,251 | $0.02 | $0.02 | $0.02 |
| 13 Aug 2024 | $0.02 | $0.00 | 0.00% | 615,496 | $0.02 | $0.02 | $0.02 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Alan Maclean Boyd | Non-Executive Director | Jun 2018 |
Mr Boyd was the Chief Financial Officer of Ridley Corporation Limited, an ASX-listed provider of high-performance animal nutrition solutions. Prior to his role, Alan occupied the same position with listed biotechnology companies Avexa Limited and Zenyth Therapeutics Limited, website pioneer Sausage Software Limited, and un-listed public entity HRL Limited, where he later served as a non-executive director and Chair of the Audit Committee. Alan started his professional career in chartered accounting firms in England and Australia and has broad financial experience across many industry sectors.
He is Chair of Risk and Compliance Management Committee. |
| Mr Vaughan Webber | Non-Executive ChairmanNon-Executive Director | Aug 2024 |
Mr Webber is a company director and finance executive with over 20 years of experience, His career highlights include Non-Executive Director, HUB24 Ltd (ASX:HUB) (2012-2018), Independent Chairman, Wentworth Holdings Ltd (ASX:WWM) (2009-2013) ,Ltd (ASX:TOP) Independent Chairman, Solvar Ltd (ASX:SVR) (2014-2016), Non-Executive Director, Anchor Resources Ltd (ASX:AHR) (2011-2019). Mr Webber currently holds a number of Board roles including Chairman in the private sector.
|
| Mr Joshua Michael Fegan | Chief Executive OfficerManaging Director | Jun 2018 |
Mr Fegan is the founder of Althea Group Holdings Limited and has extensive experience in business building, sales and marketing. He has a range of proven business and strategy skills and has previously held a number of senior management roles at national value-based retailer, Strathfield Group. Joshua founded Althea Health and Wellbeing.
|
| Penelope Dobson | Non-Executive Director | Nov 2018 |
Ms Dobson is an experienced global healthcare executive. She has worked in the broad life-science space since her training as a pharmacist in New Zealand, including many years in the global pharmaceutical industry. Penny is currently a Principal at Valida Consulting, offering a range of services to companies in the healthcare, Pharma,
Biotech, not-for-profit, Device and Diagnostics sector. She is member of Risk and Compliance Management Committee. |
| Mr Robert Meissner | Chief Financial OfficerCompany Secretary | Apr 2019 |
-
|
| Robert Meissner | Chief Financial OfficerCompany Secretary |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| Joshua Michael Fegan | 56,250,000 | 14.34% |
| Hsbc Custody Nominees (Australia) Limited | 26,002,357 | 6.63% |
| Citicorp Nominees Pty Limited | 11,055,551 | 2.82% |
| Obsidian Global Gp Llc | 10,360,036 | 2.64% |
| Mancann Pty Ltd | 10,000,000 | 2.55% |
| Hootch Pty Ltd | 7,500,000 | 1.91% |
| Hosanda Corporation Pty Limited | 4,250,000 | 1.08% |
| Bnp Paribas Nominees Pty Ltd <Ib. Au Noms Retail Client Drp> | 4,249,269 | 1.08% |
| Mr Ingo Appel | 4,000,000 | 1.02% |
| Mid Dig Investments Pty Ltd <Mid Dig Super Fund A/C> | 3,761,813 | 0.96% |
| Mr Philip John Cawood | 2,770,834 | 0.71% |
| Pither Investments Pty Ltd <Pither Investments A/C> | 2,550,000 | 0.65% |
| Tilkeridis Investments Pty Ltd <Tilkeridis Family A/C> | 2,400,763 | 0.61% |
| Pac Partners Securities Pty Ltd | 2,397,545 | 0.61% |
| J P Morgan Nominees Australia Pty Limited | 2,385,664 | 0.61% |
| Nurturing Evolutionary Development Pty Ltd | 2,180,000 | 0.56% |
| Adman Lanes Pty Ltd | 2,150,000 | 0.55% |
| Mr Hooi Giap Toh <Yang And Toh Family A/C> | 2,000,000 | 0.51% |
| Palmos Investments Pty Limited <Palmos Property A/C> | 2,000,000 | 0.51% |
| Mr Robin Poulose Thekkekara | 1,891,745 | 0.48% |
